Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xin Xue
Institutions:
Nanjing University of Chinese Medicine,
China Pharmaceutical University
Observed institutions:
Nanjing University of Chinese Medicine,
China Pharmaceutical University,
Tasly Holding Group (China),
State Key Laboratory of Natural Medicine
ORCID:
0000-0001-6143-2921
Observed ORCID:
0000-0001-6143-2921
OpenAlex ID:
A5101875950
Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease
2017
·
Wen-Yu Wu
, Yu-Chen Dai
, et al.
·
Journal of Enzyme Inhibition and Medicinal Chemistry
·
80
Medicinal Chemistry Strategies for the Development of Bruton’s Tyrosine Kinase Inhibitors against Resistance
2022
·
Shan-Liang Sun
, Shi-Han Wu
, et al.
·
Journal of Medicinal Chemistry
·
54
Natural products as potential lead compounds to develop new antiviral drugs over the past decade
2023
·
Jing-Han Zhao
, Yue-Wei Wang
, et al.
·
European Journal of Medicinal Chemistry
·
50
3-Aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as Potent Nrf2/ARE Inducers in Human Cancer Cells and AOM-DSS Treated Mice
2013
·
Mei-yang Xi
, Jian-min Jia
, et al.
·
Journal of Medicinal Chemistry
·
44
Non-coding RNAs as therapeutic targets in cancer and its clinical application
2024
·
Xuejiao Leng
, Mengyuan Zhang
, et al.
·
Journal of Pharmaceutical Analysis
·
34
Discovery of novel inhibitors disrupting HIF-1α/von Hippel–Lindau interaction through shape-based screening and cascade docking
2016
·
Xin Xue
, Ning-Yi Zhao
, et al.
·
PeerJ
·
34
Effective Screening Strategy Using Ensembled Pharmacophore Models Combined with Cascade Docking: Application to p53-MDM2 Interaction Inhibitors
2013
·
Xin Xue
, Jin-Lian Wei
, et al.
·
Journal of Chemical Information and Modeling
·
31
Synthesis and bioevaluation of a series of α-pyrone derivatives as potent activators of Nrf2/ARE pathway (part I)
2013
·
Mei-yang Xi
, Zhong-ying Sun
, et al.
·
European Journal of Medicinal Chemistry
·
31
An efficient strategy for digging protein-protein interactions for rational drug design - A case study with HIF-1α/VHL
2021
·
Xin Xue
, Ji-Bo Kang
, et al.
·
European Journal of Medicinal Chemistry
·
22
Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations
2024
·
Zi-Xuan Wang
, Qing-Qing Li
, et al.
·
Journal of Medicinal Chemistry
·
21
Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemia
2022
·
Ji-Bo Kang
, Lu Chen
, et al.
·
Bioorganic & Medicinal Chemistry
·
14
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations
2024
·
Tian-Hua Wei
, Zi-Xuan Wang
, et al.
·
Journal of Medicinal Chemistry
·
13
Design, Synthesis, and Biological Evaluation of Scutellarein Derivatives Based on Scutellarin Metabolic MechanismIn Vivo
2016
·
Ze‐Xi Dong
, Zhi‐Hao Shi
, et al.
·
Chemical Biology & Drug Design
·
12
Synthesis and Bioactivity Characterization of Scutellarein Sulfonated Derivative
2017
·
Ting Gu
, Yue Zhong
, et al.
·
Molecules
·
9
PDF
Design and Synthesis of Selective FLT3 Inhibitors Via Exploration of Back Pocket II
2023
·
Qing-Xin Wang
, Yu-Hao Cao
, et al.
·
Future Medicinal Chemistry
·
8
Tumor-Targeting NIRF/MR Dual-Modal Molecular Imaging Probe for Surgery Navigation
2022
·
Qiyi Li
, Xin Xue
, et al.
·
Analytical Chemistry
·
8
Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemia
2023
·
Shan-Liang Sun
, Jia-Zhen Wu
, et al.
·
Biomedicine & Pharmacotherapy
·
7
Discovery of 4‐(4‐aminophenyl)‐6‐phenylisoxazolo[3,4‐b]pyridine‐3‐amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemia
2023
·
Qing‐Xin Wang
, Yi‐Bo Wang
, et al.
·
Drug Development Research
·
7
PDF
Protective effect of 6-O-methyl-scutellarein on repeated cerebral ischemia/reperfusion in rats
2017
·
Wen-Yu Wu
, Yue Zhong
, et al.
·
Journal of Asian Natural Products Research
·
7
Novel IKKβ inhibitors discovery based on the co-crystal structure by using binding-conformation-based and ligand-based method
2013
·
Jing-Jie Huang
, Xiao-Wen Wu
, et al.
·
European Journal of Medicinal Chemistry
·
7
Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging
2024
·
Yan-Cheng Yu
, Zhen-Jiang Tong
, et al.
·
Journal of Medicinal Chemistry
·
5
Scaffold-hopping of Linifanib to Design 6-phenylisoxazolo[3,4-b]pyridin-3-amine Derivatives as FLT3 Inhibitors for Treating Acute Myeloid Leukemia
2023
·
Shi-Han Wu
, Yi-Yuan Ma
, et al.
·
Letters in Drug Design & Discovery
·
5
Metabolite Profiling of Danatinib in Mice Using Ultra‐High‐Performance Liquid Chromatography/Tandem Mass Spectrometry In Vitro and In Vivo
2025
·
Meng‐Yuan Zhang
, Yuan‐Wei Zhang
, et al.
·
Biomedical Chromatography
·
4
PDF
Discovery of natural products as influenza neuraminidase inhibitors: in silico screening, in vitro validation, and molecular dynamic simulation studies
2025
·
Binglin Huang
, Bijuan Lin
, et al.
·
Molecular Diversity
·
4
Kinase-Bench: Comprehensive Benchmarking Tools and Guidance for Achieving Selectivity in Kinase Drug Discovery
2024
·
Tian-Hua Wei
, Shuang-Shuang Zhou
, et al.
·
Journal of Chemical Information and Modeling
·
4
Show more works
View as search
Works count:
41
Citation count:
538
H-index:
12
I10-index:
13
Year
Topic
Type